24350

0

NEPHROCARE

img img img img
No Data Available

NEPHRO CARE INDIA LIMITED Share Price Update

As of the latest trading session, NEPHRO CARE INDIA LIMITED is trading at ₹82.35, up by ₹2.59 or 3.24% from its previous close. The stock has moved between ₹79.55 and ₹82.50 today. Over the past year, the stock has delivered a return of -42.02%. In the last month, it has returned 54.10%.

NEPHRO CARE INDIA LIMITED performance

Today’s low Today’s high
₹ 79.55 ₹ 82.50
₹ 82.35
52 week low 52 week high
₹ 50.05 ₹ 183.00
₹ 82.35
Open Price ₹ 79.55
Prev. Close ₹ 79.75
Volume (Shares) 2400.00
Total traded value ₹ 1.97
Upper Circuit ₹ 95.70
Lower Circuit ₹ 63.80
info

Investment Returns

Over 1 Month 54.10% Over 3 Months -20.40% Over 6 Months -41.23% Over 1 Year -42.02%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

NEPHRO CARE INDIA LIMITED fundamentals


  • Market cap (Cr) 135.80
  • P/E Ratio (TTM) 36.09
  • Beta 1.30
  • Book Value / share 32.44
  • Return on equity 8.38%
  • EPS (TTM) 1.74
  • Dividend yield 0.00%
  • Net profit/quarter (Cr) 0.42
info icon alternate text
  • Market cap (Cr) [-]
  • P/E Ratio (TTM) [-]
  • Beta [-]
  • Book Value / share [-]
  • Return on equity [-]%
  • EPS (TTM) [-]
  • Dividend yield 0.00%
  • Net profit/quarter (Cr) [-]
info icon alternate text

NEPHRO CARE INDIA LIMITED Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition
info-icon
Revenue
Net income
Particulars DEC 2025 (Values in Cr)
Revenue 22.66
Operating Expense 22.18
Net Profit 0.42
Net Profit Margin (%) 1.85
Earnings Per Share (EPS) 0.26
EBITDA 1.99
Effective Tax Rate (%) 25.00
Particulars MAR 2024 (Values in Cr)
Revenue 7.48
Operating Expense 0.00
Net Profit 1.01
Net Profit Margin (%) 13.50
Earnings Per Share (EPS) 0.85
EBITDA 0.00
Effective Tax Rate (%) 0.00
Particulars DEC 2023 (Values in Cr)
Revenue 6.65
Operating Expense 0.00
Net Profit -0.25
Net Profit Margin (%) -3.75
Earnings Per Share (EPS) 0.00
EBITDA 0.00
Effective Tax Rate (%) 0.00
Particulars MAR 2025 (Values in Cr)
Revenue 46.03
Operating Expense 42.73
Net Profit 3.64
Net Profit Margin (%) 7.90
Earnings Per Share (EPS) 2.38
EBITDA 7.40
Effective Tax Rate (%) 24.63
Particulars MAR 2024 (Values in Cr)
Revenue 27.23
Operating Expense 21.38
Net Profit 4.41
Net Profit Margin (%) 16.19
Earnings Per Share (EPS) 3.80
EBITDA 6.84
Effective Tax Rate (%) 27.65
Particulars MAR 2023 (Values in Cr)
Revenue 17.09
Operating Expense 14.52
Net Profit 2.37
Net Profit Margin (%) 13.86
Earnings Per Share (EPS) 38.85
EBITDA 3.42
Effective Tax Rate (%) 7.75
Particulars MAR 2022 (Values in Cr)
Revenue 3.42
Operating Expense 3.43
Net Profit -0.01
Net Profit Margin (%) -0.29
Earnings Per Share (EPS) -0.20
EBITDA 0.13
Effective Tax Rate (%) 0.00
Particulars MAR 2021 (Values in Cr)
Revenue 1.82
Operating Expense 1.71
Net Profit 0.09
Net Profit Margin (%) 4.94
Earnings Per Share (EPS) 88.70
EBITDA 0.16
Effective Tax Rate (%) 25.00
Particulars MAR 2025 (Values in Cr)
Book Value / Share 32.44
ROE % 8.38
ROCE % 11.18
Total Debt to Total Equity 0.00
EBITDA Margin 13.70
Particulars MAR 2024 (Values in Cr)
Book Value / Share 12.62
ROE % 50.26
ROCE % 61.86
Total Debt to Total Equity 0.14
EBITDA Margin 24.47
Particulars MAR 2023 (Values in Cr)
Book Value / Share 50.57
ROE % 156.44
ROCE % 65.51
Total Debt to Total Equity 1.65
EBITDA Margin 18.84
Particulars MAR 2022 (Values in Cr)
Book Value / Share 9.90
ROE % -153.85
ROCE % 1.59
Total Debt to Total Equity 6.22
EBITDA Margin 4.09
Particulars MAR 2021 (Values in Cr)
Book Value / Share 15.00
ROE % 450.00
ROCE % 20.83
Total Debt to Total Equity 34.57
EBITDA Margin 8.79
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 4.65
Total Assets 68.28
Total Liabilities 68.28
Total Equity 53.48
Share Outstanding 1
Price to Book Ratio 3.92
Return on Assets (%) 5.32
Return on Capital (%) 6.8
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 1.29
Total Assets 20.96
Total Liabilities 20.96
Total Equity 15.02
Share Outstanding 1
Price to Book Ratio 0.00
Return on Assets (%) 21.03
Return on Capital (%) 29.36
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 2.31
Total Assets 8.25
Total Liabilities 8.25
Total Equity 2.52
Share Outstanding 0
Price to Book Ratio 0.00
Return on Assets (%) 28.72
Return on Capital (%) 47.35
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 0.60
Total Assets 4.62
Total Liabilities 4.62
Total Equity 0.49
Share Outstanding 0
Price to Book Ratio 0.00
Return on Assets (%) -0.21
Return on Capital (%) -0.32
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 0.48
Total Assets 1.28
Total Liabilities 1.28
Total Equity 0.21
Share Outstanding 0
Price to Book Ratio 0.00
Return on Assets (%) 10.53
Return on Capital (%) 14.85
Particulars MAR 2025 (Values in Cr)
Net Income 4.82
Cash from Operations 9.06
Cash from Investing -39.55
Cash from Financing 35.10
Net change in Cash 3.36
Free Cash Flow 38.27
Particulars MAR 2024 (Values in Cr)
Net Income 6.22
Cash from Operations 3.20
Cash from Investing -7.53
Cash from Financing 5.60
Net change in Cash -1.02
Free Cash Flow 5.63
Particulars MAR 2023 (Values in Cr)
Net Income 2.57
Cash from Operations 4.16
Cash from Investing -2.33
Cash from Financing -0.08
Net change in Cash 1.70
Free Cash Flow 4.66
Particulars MAR 2022 (Values in Cr)
Net Income 0.00
Cash from Operations 0.68
Cash from Investing -2.81
Cash from Financing 2.32
Net change in Cash 0.12
Free Cash Flow 2.13
Particulars MAR 2021 (Values in Cr)
Net Income 0.11
Cash from Operations 0.19
Cash from Investing -0.06
Cash from Financing 0.27
Net change in Cash 0.44
Free Cash Flow 0.26
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
APOLLO HOSPITALS ENTER. L 7639.20 60.47 12.08 109839.98 6680.00 8099.00
FORTIS MALAR HOSPITALS LIMITED 56.00 23.14 3.05 104.95 40.75 81.00
SHREE PACETRONIX LTD. 135.36 20.42 2.99 50.76 66.10 283.15
TRANSGENE BIOTEK LTD. 2.75 0.00 2.26 20.84 1.83 5.26
VIMTA LABS LIMITED 478.55 35.16 6.23 2137.65 377.30 902.85
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
APOLLO HOSPITALS ENTER. L 7639.20 75.63 11.79 109839.98 6680.00 8099.00
[-] 0.0 0.0 0.0 0.0 0.0 0.0
CHENNAI MEENAKSHI MULTISPECIAL 39.20 0.00 -11.39 29.28 30.02 57.48
KOVAI MEDICAL CENTER & HOSPITA 5665.45 26.28 5.20 6198.00 5010.00 6725.00

NEPHRO CARE INDIA LIMITED shareholding pattern

Holding
35.05%
61.46%
3.47%
Name Shares Category
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)

NEPHRO CARE INDIA LIMITED Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
82.35 3.26 redarrow
red-green-graph indicator
10 Bearish
6 Bullish
  • 5 Days 84.50
  • 26 Days 79.10
  • 10 Days 83.80
  • 50 Days 80.70
  • 12 Days 83.10
  • 100 Days 91.70
  • 20 Days 80.30
  • 200 Days 113.00
87.88 PIVOT
First Support 86.87 First Resistance 89.62 Second Support 85.13 Second Resistance 90.63 Third Support 84.12 Third Resistance 92.37
RSI 50.92 ADX 25.02 MACD 3.94 Williams % R -58.97 Commodity Channel Index (CCI) 14.60
Date 2026-04-30 Week 14000.00 Same Day 31600.00 Month 16019.00
1 Year 1.31 3 Year 1.29
Over 1 Month
54.10% down
Over 1 Year
-42.02% down
Over 3 Months
-20.40% down
Over 3 Years
0.00% down
Over 6 Months
-41.23% down
Over 5 Years
0.00% down

NEPHRO CARE INDIA LIMITED Corporate Actions

Top Gainers

Top Losers

NEPHRO CARE INDIA LIMITED Share Price

Nephro Care India Limited was originally incorporated on July 08, 2014 as a Private Limited Company as 'Nephro Care India Private Limited' with the Registrar of Companies, West Bengal. Subsequently, Company converted into a Public Limited Company and the name of Company was changed to Nephro Care India Limited' and a fresh Certificate of Incorporation dated March 5, 2024, was issued by the Registrar of Companies, Central Processing Centre.

Nephro Care was founded in the year 2014 by Dr. Pratim Sengupta in Kolkata with an object of providing comprehensive medical services for renal patients. The Company is a one stop treatment centre based in Kolkata that offer clinical and lifestyle solutions and services and renal insufficiency treatment to patients. The treatment framework covers the entire range of lifestyle, physiological and spiritual aspects of wellness.

The main business of the company is to provide comprehensive 360 Degree healthcare servicing to the patients with kidney related services, The Company operate only in non -invasive service, their operations have been supported by a pool of expert Doctors, experienced and well-trained paramedical professionals and a skilled management team. The entire team is further supported by sufficient clinical and investigative infrastructure.

The Company in 2021, started flagship Salt Lake, Kolkata clinic; it started two satellite clinics operations at Chandannagar, in West Bengal in 2023, by taking up a Dialysis unit with e-Age Healthcare. The high cost of dialysis care has led to financial hardship for practically all families with such patients. Apart from this, the clinics have been equipped with technologically advanced equipment and diagnostic instruments.

At present, Nephro Care offers the services at their clinics following Inhouse Dialysis Unit; Outpatient Services in areas of Nephrology, Diabetology, Cardiology, Ophthalmology and Neurology; NABL accredited inhouse Pathology; Inhouse Pharmacy; Advance diagnostic facilities; Renal Nutrition department; Home Care; Mukti (Lifestyle Support Program) and Home Dialysis. Besides, it has in house diagnostic tools including UGS, ECHO, ECG, X Ray, PFT, NCB, Fibroscan, Sudoscan, Fundoscopy, BCM, Polysomnography, Holter monitoring which ensure complete screening and accurate diagnosis.

The Company launched its IPO comprising a fresh issue of 45,84,000 equity shares of Rs 10 per equity shares by raising Rs 41.25 crores on July 02, 2024.

On 1st July, 2024, the company inaugurated a state of the art renal care clinic in Alipurduar, West Bengal. The Company opened its Vivacity Multispecialty Hospital in Madhyamgram, Kolkata in 2025. It launched a Cardiothoracic & Vascular Surgery (CTVS) unit to deliver advanced cardiac and vascular care to residents of North 24 Parganas district. On 1st March, 2025, the company has inaugurated its new unit in the heart of Kolkata in Shyambazar.

Parent organization Indian Private
NSE symbol NEPHROCARE
Founded 2014
stock
Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Nephro Care India Ltd?

Answer Field

Nephro Care India Ltd share price is for NSE ₹ 82.35 & for BSE ₹ 0.00 as on May 04 2026 12:38 PM.

What is the Market Cap of Nephro Care India Ltd Share?

Answer Field

The market cap of Nephro Care India Ltd for NSE ₹ 135.80 & for BSE ₹ 0.00 as on May 04 2026 12:38 PM.

What is the 52 Week High and Low of Nephro Care India Ltd?

Answer Field

The 52 Week High and Low of Nephro Care India Ltd for NSE is ₹ 183.00 and ₹ 50.05 and for BSE is ₹ 0.00 and ₹ 0.00.

What is 1 year return for Nephro Care India Ltd?

Answer Field

The 1 year returns on the stock has been -42.02%.

What is the P/E Ratio of Nephro Care India Ltd Share?

Answer Field

As on May 04 2026 12:38 PM the price-to-earnings (PE) ratio for Nephro Care India Ltd share is 36.09.

What is the PB ratio of Nephro Care India Ltd Share?

Answer Field

As on May 04 2026 12:38 PM, the price-to-book (PB) ratio for Nephro Care India Ltd share is 32.44.

How to Buy Nephro Care India Ltd Share?

Answer Field

You can trade in Nephro Care India Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Nephro Care India Ltd Share on Bajaj Broking App?

Answer Field

To buy Nephro Care India Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Nephro Care India Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image

Get Free Demat Account*

+91
close-img

Authorise with OTP

Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59
banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|